42 studies found for:
" March 09, 2011":" April 08, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements
|
||||
| 2 | Recruiting |
Project RAP: Family-based HIV Prevention in the Juvenile Drug Court
|
||||
| 3 | Recruiting |
Enhancement of Connect to Protect® (C2P)
|
||||
| 4 | Unknown † |
Improving Antiretroviral Medication Adherence Among HIV-infected Youth
|
||||
| 5 | Completed |
Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey
|
||||
| 6 | Active, not recruiting |
Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen
|
||||
| 7 | Recruiting |
Dating Violence and HIV Prevention in Girls: Adapting Mental Health Interventions
|
||||
| 8 | Active, not recruiting |
Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)
|
||||
| 9 | Completed |
Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM)
|
||||
| 10 | Recruiting |
The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART
|
||||
| 11 | Active, not recruiting |
Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin
|
||||
| 12 | Completed |
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects
|
||||
| 13 | Completed |
EuroSIDA As An External Comparator To MOTIVATE Trials
|
||||
| 14 | Active, not recruiting |
Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection
|
||||
| 15 | Recruiting |
Microparticles, Vector of Genetic Information During HIV Infection
|
||||
| 16 | Recruiting |
The VMVN Study: Virological Monitoring in Viet Nam
|
||||
| 17 | Completed |
Role of HIV on Glutathione Synthesis and Oxidative Stress
|
||||
| 18 | Recruiting |
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors
|
||||
| 19 | Recruiting |
HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women
|
||||
| 20 | Unknown † |
Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis
|
† Indicates status has not been verified in more than two years
